This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Johanna Simon, Ph.D.
Principal Scientist Early Formulation Screening Service at MilliporeSigma


Johanna Simon, PhD, is a Principial Scientist in the Early Formulation Screening Service in Life Science Services at MilliporeSigma. Her work focuses on the preclinical formulation development of custom lipid nanoparticles for nucleic acid modalities. After receiving her Ph.D. in Chemistry, Johanna has continued her scientific career as a postdoctoral researcher with a focus on developing antibody-functionalized nanoparticles for targeted drug delivery in vivo. Johanna has authored 50+ peer-reviewed articles in leading journals in the field of drug delivery sciences.

Agenda Sessions

  • Mastering Lipid Nanoparticle Formulation Development – Early Formulation Screening As Key Asset to Our Integrated CTDMO Offering


Speakers at this event